Peptídeos
Subcategorias de "Peptídeos"
Foram encontrados 29887 produtos de "Peptídeos"
MSH5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MSH5 antibody, catalog no. 70R-5575
Pureza:Min. 95%GRK7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GRK7 antibody, catalog no. 70R-9903
Pureza:Min. 95%DDX50 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DDX50 antibody, catalog no. 70R-1367
Pureza:Min. 95%CXCR4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CXCR4 antibody, catalog no. 70R-7849
Pureza:Min. 95%C14ORF130 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C14orf130 antibody, catalog no. 70R-1165
Pureza:Min. 95%SCG3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SCG3 antibody, catalog no. 70R-9777
Pureza:Min. 95%C2orf25 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C2orf25 antibody, catalog no. 70R-4055
Pureza:Min. 95%Peptide YY(3-36), PYY, human
Custom research peptide; min purity 95%.
Fórmula:C180H279N53O54Pureza:Min. 95%Peso molecular:4,049.55 g/molRef: 3D-PP17072
Produto descontinuadoPANK4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PANK4 antibody, catalog no. 70R-2710
Pureza:Min. 95%ERCC4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ERCC4 antibody, catalog no. 70R-2117
Pureza:Min. 95%RHOT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RHOT1 antibody, catalog no. 70R-5954Pureza:Min. 95%Pigs Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Pigs antibody, catalog no. 70R-8862
Pureza:Min. 95%C3orf49 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C3orf49 antibody, catalog no. 70R-4569
Pureza:Min. 95%AKR1C2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AKR1C2 antibody, catalog no. 70R-4046
Pureza:Min. 95%CENPP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CENPP antibody, catalog no. 70R-2175
Pureza:Min. 95%ANKRD39 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANKRD39 antibody, catalog no. 70R-9456
Pureza:Min. 95%ZNF668 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF668 antibody, catalog no. 70R-7997
Pureza:Min. 95%RBM12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RBM12 antibody, catalog no. 70R-5030
Pureza:Min. 95%WDSUB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of WDSUB1 antibody, catalog no. 70R-2815
Pureza:Min. 95%XRCC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of XRCC3 antibody, catalog no. 70R-10279
Pureza:Min. 95%KIF21A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KIF21A antibody, catalog no. 70R-5567
Pureza:Min. 95%AIFM3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AIFM3 antibody, catalog no. 70R-2470
Pureza:Min. 95%DDX19A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DDX19A antibody, catalog no. 70R-1339
Pureza:Min. 95%PUS7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PUS7 antibody, catalog no. 70R-1241
Pureza:Min. 95%HERC5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HERC5 antibody, catalog no. 70R-5524
Pureza:Min. 95%LRRC50 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC50 antibody, catalog no. 70R-3850
Pureza:Min. 95%RHOT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RHOT1 antibody, catalog no. 70R-5953
Pureza:Min. 95%LONRF3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LONRF3 antibody, catalog no. 70R-2616
Pureza:Min. 95%ACP5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACP5 antibody, catalog no. 70R-3911
Pureza:Min. 95%QARS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of QARS antibody, catalog no. 70R-9414
Pureza:Min. 95%PCMT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PCMT1 antibody, catalog no. 70R-1558
Pureza:Min. 95%PNMA2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PNMA2 antibody, catalog no. 70R-9173
Pureza:Min. 95%Ndufv2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Ndufv2 antibody, catalog no. 70R-9509
Pureza:Min. 95%GPI Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPI antibody, catalog no. 70R-10234
Pureza:Min. 95%Hps3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Hps3 antibody, catalog no. 70R-7822
Pureza:Min. 95%Bovine Serum Albumin
CAS:Bovine Serum Albumin (BSA) is a protein that is used in the pharmaceutical industry as a research tool and an immunological reagent. BSA can be used to bind, stabilize, and prevent denaturation of other proteins in the laboratory. It has been shown to inhibit ion channels and ligand-gated ion channels, which are important for membrane potentials. BSA is also an activator of receptor tyrosine kinases, which are involved in cell signaling pathways.
Pureza:Min. 95%Beta-Sheet Breaker Peptide iAß5
CAS:Beta-Sheet Breaker Peptide iAß5 is a peptide that interacts with amyloid beta proteins to disrupt the formation of beta sheets. It has been shown to inhibit the aggregation of amyloid beta proteins into oligomers and fibrils, and disrupts the self-assembly of amyloid beta protein into various conformations. Beta-Sheet Breaker Peptide iAß5 is a ligand for both receptor and activator binding sites on amyloid beta proteins, inhibiting the interaction of these sites. This inhibits the activation of downstream signalling pathways associated with Alzheimer's disease.
Fórmula:C33H43N5O8Pureza:Min. 95%Peso molecular:637.72 g/molNSMCE1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NSMCE1 antibody, catalog no. 70R-2769
Pureza:Min. 95%ZNF529 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF529 antibody, catalog no. 70R-8358
Pureza:Min. 95%FZD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FZD2 antibody, catalog no. 70R-7184
Pureza:Min. 95%SULT6B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SULT6B1 antibody, catalog no. 70R-2595
Pureza:Min. 95%Anti IL-1alpha (Rat) Serum
Anti IL-1alpha (Rat) Serum is a serum that provides an inhibitor for IL-1alpha. The serum is used in the study of peptides and cell biology. This serum is made from high purity, life science grade material and has been shown to be effective in inhibiting the activation of ion channels.
Pureza:Min. 95%Corticostatin, human
Catalogue peptide; min. 95% purity
Fórmula:C157H261N49O43S6Peso molecular:3,715.47 g/molp3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54-68)
Catalogue peptide; min. 95% purity
Fórmula:C59H97N17O19Peso molecular:1,348.53 g/molBTK derived peptide
Catalogue peptide; min. 95% purity
Fórmula:C72H115N17O18S2Peso molecular:1,570.95 g/molGrowth Hormone Releasing Factor, GRF (1-40), amide, human
Catalogue peptide; min. 95% purity
Fórmula:C194H318N62O62SPeso molecular:4,543.14 g/molBig Gastrin-1, human
Catalogue peptide; min. 95% purity
Fórmula:C176H251N43O53SPeso molecular:3,849.30 g/molInsulin Receptor (1142-1153)
Catalogue peptide; min. 95% purity
Fórmula:C72H107N19O24Peso molecular:1,622.77 g/molADP-Ribosylation Factor 6, ARF6 (2-13)
Catalogue peptide; min. 95% purity
Fórmula:C60H102N16O17Peso molecular:1,319.58 g/molAc-a-CGRP (19-37) (human)
Catalogue peptide; min. 95% purity
Fórmula:C88H139N25O26Peso molecular:1,963.24 g/molAc-Adhesin (1025-1044) amide
Catalogue peptide; min. 95% purity
Fórmula:C97H160N26O32Peso molecular:2,202.51 g/molIntermedin (rat)
Catalogue peptide; min. 95% purity
Fórmula:C226H361N75O64S2Peso molecular:5,216.99 g/mol[Arg0] Met-Enkephalin
Catalogue peptide; min. 95% purity
Fórmula:C33H47N9O8SPeso molecular:729.86 g/molP69 (522-534), M. leprae
Catalogue peptide; min. 95% purity
Fórmula:C52H84N14O21Peso molecular:1,241.33 g/molBiotin-[Tyr0]-Orexin B, mouse, rat
Catalogue peptide; min. 95% purity
Fórmula:C145H238N48O38S2Peso molecular:3,325.86 g/mol[Ala8]-Humanin, [Ala8]-HN, Shna
Catalogue peptide; min. 95% purity
Fórmula:C119H204N34O32SPeso molecular:2,655.23 g/molCrustacean Erythrophore Concentrating Hormone
Catalogue peptide; min. 95% purity
Fórmula:C45H59N11O11Peso molecular:930.04 g/molPeptide YY (3-36) (canine, mouse, porcine, rat)
Catalogue peptide; min. 95% purity
Fórmula:C190H288N54O57Peso molecular:4,240.64 g/molFluorescein-6-carbonyl-Leu-Glu(OMe)-His-DL-Asp(OMe)-fluoromethylketone
CAS:Please enquire for more information about Fluorescein-6-carbonyl-Leu-Glu(OMe)-His-DL-Asp(OMe)-fluoromethylketone including the price, delivery time and more detailed product information at the technical inquiry form on this page
Fórmula:C45H47FN6O14Pureza:Min. 95%Peso molecular:914.89 g/mol[Trp11] Neurotensin (8-13)
Catalogue peptide; min. 95% purity
Fórmula:C40H65N13O7Peso molecular:840.05 g/molRef: 3D-VAC-00688
Produto descontinuadoAc-Choline Receptor α1(129-145)
Catalogue peptide; min. 95% purity
Fórmula:C90H136N22O28S2Peso molecular:2,038.34 g/molbeta-Lipotropin (1-10), porcine
Catalogue peptide; min. 95% purity
Fórmula:C42H66N10O15Peso molecular:951.05 g/molCJC-1295
CAS:CJC-1295 is a synthetic peptide, which is an analogue of growth hormone-releasing hormone (GHRH). It is synthesized through recombinant DNA technology, which allows for precise control over its sequence and length. This particular peptide is designed to bind to GHRH receptors in the pituitary gland. By activating these receptors, CJC-1295 stimulates the release of growth hormone (GH) into the bloodstream.The primary function of CJC-1295 is to influence the endocrine system, particularly enhancing the release of endogenous growth hormone. It achieves this by increasing the amplitude and frequency of GH pulses without affecting the natural negative feedback mechanisms that regulate GH production. This mode of action distinguishes CJC-1295 from other growth hormone therapies, as it promotes a more physiological pattern of hormone secretion.CJC-1295 is used in various scientific contexts, primarily in research focusing on growth hormone deficiencies, muscle wasting conditions, and certain metabolic disorders. Its ability to increase GH release also makes it a subject of interest in studies related to aging, tissue repair, and regeneration. The longer half-life of CJC-1295 compared to natural GHRH peptides further enhances its applications in research, allowing for more sustained and controlled experimentation.
Pureza:Min. 95%Ref: 3D-FC138107
Produto descontinuadoMyelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) trifluoroacetate
CAS:Myelin oligodendrocyte glycoprotein (MOG) is a myelin protein found in the central nervous system. MOG is a ligand for CD200, which is an inhibitory receptor expressed by astrocytes. It has been shown that MOG can induce the proliferation and differentiation of primary cultures of rat astrocytes in vitro. MOG induces the production of reactive oxygen species in mitochondria and increases the expression of acid-binding protein, which are both important factors in the demyelination process. MOG has also been implicated as a potential factor in the development of multiple sclerosis. Further research into this protein may lead to new treatments or cures for disorders such as encephalomyelitis, nervous system diseases, or even cancer.
Fórmula:C118H177N35O29S•C2HO2F3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:2,695.98 g/molRef: 3D-FM109206
Produto descontinuadoAngiotensin II type 1 receptor (181-187), AT1, ATE.
Catalogue peptide; min. 95% purity
Fórmula:C40H52N10O13Peso molecular:880.92 g/mol2A/2B Dengue Protease Substrate
Catalogue peptide; min. 95% purity
Fórmula:C39H68N16O11Peso molecular:937.08 g/mol[Phe22] Big Endothelin-1 (19-37), human
Catalogue peptide; min. 95% purity
Fórmula:C104H152N26O26Peso molecular:2,182.53 g/molSomatostatin-28 (1-14)
Catalogue peptide; min. 95% purity
Fórmula:C61H105N23O21SPeso molecular:1,528.72 g/molBrain injury Derived Neurotrophic Peptide(3) BINP
Catalogue peptide; min. 95% purity
Fórmula:C62H101N17O19Peso molecular:1,388.58 g/molFMRF-related peptide, SDPFLRF-NH2
Catalogue peptide; min. 95% purity
Fórmula:C42H61N11O10Peso molecular:880.02 g/molH-His-Arg-OH
CAS:H-His-Arg-OH is a synthetic peptide that has been shown to have cytotoxic effects on mammalian cells. The H-His-Arg-OH peptide can be used for the treatment of heart disease and autoimmune diseases, such as rheumatoid arthritis. This peptide has been found to be resistant to congestive heart failure, which is caused by a number of factors, including hypertension and valvular stenosis. It has also been shown to have an immunoglobulin G1 (IgG1) genotype.
Fórmula:C12H21N7O3Pureza:Min. 95%Peso molecular:311.34 g/molRef: 3D-FH108062
Produto descontinuadoPrepro TRH (53-74)
Catalogue peptide; min. 95% purity
Fórmula:C118H182N32O32Peso molecular:2,560.96 g/mol[Met2]-Deltorphin
Catalogue peptide; min. 95% purity
Fórmula:C44H62N10O10S2Peso molecular:955.17 g/molDisulfide biotin azide
CAS:Extraordinary strength of the streptavidin-biotin interaction allows for efficient capturing of even highly dilute targets; however, it makes recovery of proteins from affinity resins challenging. Conventional methods to elute biotinylated proteins from immobilized avidin include the following: (i) denaturation of streptavidin by boiling the resin in a denaturing buffer that may include high concentrations of chaotropic salts, (ii) trypsin digestion of proteins while they are bound to the resin, or (iii) elution of proteins with excess free biotin. These protocols can co-elute contaminant proteins by releasing nonspecifically bound proteins and/or naturally biotinylated proteins concurrently with labeled proteins. In addition, some of these methods can cause elution of high levels of resin-based peptides along with the proteins of interest, resulting in further sample contamination.
Disulfide Biotin Azide probe eliminates a major limitation of the streptavidin-biotin affinity purification. This reagent contains a biotin moiety linked to an azide moiety through a spacer arm containing a cleavable disulfide linker. Captured biomolecules can be efficiently released under mild conditions (50 mM dithiothreitol, 10 mM 2-mercaptoethanol or 1% sodium borohydride) and the small molecular fragment (188.25 Da) left on the labeled protein following cleavage. These features make the cleavable probe especially attractive for use in biomolecular labeling and proteomic studies.Fórmula:C27H48N8O7S3Pureza:Min 95%Peso molecular:692.92 g/molBiotin-Galanin, human
Catalogue peptide; min. 95% purity
Fórmula:C149H224N44O45SPeso molecular:3,383.78 g/mol[Ile12, Val15] MUC5AC Analog 3
Catalogue peptide; min. 95% purity
Fórmula:C67H112N16O25Peso molecular:1,541.73 g/mol[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human
Catalogue peptide; min. 95% purity
Fórmula:C189H285N55O57SPeso molecular:4,271.67 g/mol[Tyr0]-α-CGRP, [Tyr0]-α-CGRP, rat
Catalogue peptide; min. 95% purity
Fórmula:C171H271N51O54S2Peso molecular:3,969.50 g/mol
![[Arg0] Met-Enkephalin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00699.webp&w=3840&q=75)
![Biotin-[Tyr0]-Orexin B, mouse, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00130.webp&w=3840&q=75)
![[Ala8]-Humanin, [Ala8]-HN, Shna](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00593.webp&w=3840&q=75)
![[Trp11] Neurotensin (8-13)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00688.webp&w=3840&q=75)
![[Phe22] Big Endothelin-1 (19-37), human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00505.webp&w=3840&q=75)
![[Met2]-Deltorphin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00898.webp&w=3840&q=75)
![[Ile12, Val15] MUC5AC Analog 3](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00456.webp&w=3840&q=75)
![[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00911.webp&w=3840&q=75)
![[Tyr0]-α-CGRP, [Tyr0]-α-CGRP, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00921.webp&w=3840&q=75)